Filing Flows

Filing Flows › Companies › Prokidney › Report card

Prokidney earnings report card

Every report on file against what analysts and the company itself expected, and what the stock did

Beat rate2 of 4 reports beat the EPS estimate

Prokidney (PROK) beat the analysts' EPS estimate in 2 of its last 4 reports (50%), by +2.2% on average. Next report: Nov 9, 2026, analysts expect EPS −$0.14.

Beat rate50% of 4
Average surprise+2.2%
Next reportNov 9, 2026

Report by report

QuarterReportedEPS est.EPS reportedSurpriseRevenue reported
Q2 2026Aug 10, 2026−$0.14−$0.15-8.7%$150K
Q1 2026May 15, 2026−$0.14−$0.14-1.8%$226K
Q4 2025Mar 18, 2026−$0.15−$0.14+7.3%$225K
Q3 2025Nov 10, 2025−$0.14−$0.12+11.9%$217K

Estimates and reported EPS are the Street's adjusted figures. Revenue reported is from the company's filing. No daily prices are on file for these report days, so the stock's moves are not shown.

Charts

Prokidney: EPS reported against the estimateProkidney: EPS reported against the estimateEstimateReported−$0.14−$0.12Q3 2025−$0.15−$0.14Q4 2025−$0.14−$0.14Q1 2026−$0.14−$0.15Q2 2026
Latest (Q2 2026): Estimate −$0.14, Reported −$0.15.

The next report: what to expect → Prokidney: every quarter →

Read automatically from SEC filings, earnings releases and public estimates; errors are possible. Not investment advice.